Skip to main content
Science
Clinical Trials
Guide to Clinical Trials
Clinical Trials in Children
Data and Results
Integrity and Transparency
Diversity
Plain Language Study Results
Expanded Access & Compassionate Use
Find a Trial
Areas of Focus
Rare Disease
Internal Medicine
Inflammation & Immunology
Vaccines
Oncology
Anti Infectives
Areas of Innovation
Medicinal Sciences
Precision Medicine
Maternal Immunization
mRNA Technology
Diseases & Conditions
Coronavirus Resources
Product Pipeline
Research Sites
Products
How Drugs are Made
Branded vs. Generic
Biologics & Biosimilars
Commitment to Quality
Global Supply
Manufacturing Sites
Medicine Safety
Health Literacy
Treatment Choices
Partnering With Patients
Tips for Patients
Reporting Adverse Events
Counterfeiting
Product Safety
Product List
Product Contacts
PfizerPro for Professionals
Patient Assistance Programs
Distributors
Pfizer Distributors
Stories
Articles
Announcements
Behind the Science Features
Podcasts
eBooks
Newsroom
Press Releases
Media Asset Library
Updates and Statements
Partnering News
Media Contacts
About
People
Executives
Board Members
Scientists
Patient Stories
Colleague Stories
Responsibility
Ethics & Compliance
Responsible Business
Patient Advocacy & Engagement
Global Impact
Diversity, Equity, and Inclusion
Environmental Sustainability
Human Rights
Health & Safety
Intellectual Property
EHS Governance
Misinformation
Programs & Policies
Grants
Political Partnership
Working with Healthcare Professionals
Prescription Value & Pricing
Privacy Principles
Ready for Cures
Transparency in Grants
Policy Positions
Corporate Governance
Corporate Governance Overview
Board Committees & Charters
The Pfizer Board Policies
Corporate Governance FAQs
Contact Our Directors
Purpose
History
Careers
Partners
Research and Business Development Partnerships
Venture Investments
Business to Business
Pfizer CentreOne
Pfizer Ignite
Submit Your Opportunities
Contact Us
Careers
Investors
Search
Contact Us
Hamburger
Changed
Changed
How can we help you?
0
search results for
Suggestions within Pfizer.com
Header close
Header close
Home
Stories
Announcements
Vaccines Announcements
Filter Options
Archive Date
Year
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Month
January
February
March
April
May
June
July
August
September
October
November
December
Type
Updates
Perspectives
View 12
View 12
View 24
View 48
Categories
Breaking News
Employees
Events
Guidance
Hiring & Recruitment
Perspectives
Updates & Statements
• • •
Keywords
All Keywords
Vaccines
Accord
Albert Bourla
Alopecia
Annual Report
Antibiotics
Antimicrobial Resistance
Artificial Intelligence
Atrial Fibrillation
Autoimmune Diseases
Biologics & Biosimilars
Blood Cancer
Breast Cancer
Business
C Difficile
COVID-19 Vaccine Efforts
Cancer
Cardiovascular Disease
Careers
Clinical Trials
Colon Cancer
Colorectal Cancer
Counterfeit Medicines
Covid-19
Diabetes
Diseases & Conditions
Diversity & Inclusion
Duchenne Muscular Dystrophy
Eczema
Emerging Medicine
Employees
Environment
Finance
Fungal Infections
Gaucher Hormone Deficiency
Gene Therapy
Government
Growth Hormone Deficiency
Health Equity
Health Literacy
Hemophilia
History
Hypertension
Immune System
Infectious diseases
Influenza
Investments
Kidney Cancer
Leadership
Leukemia
Lung Cancer
Lupus
Lyme Disease
Manufacturing
Maternal Immunization
Medicinal Science
Medicines
Meningococcal Disease
Migraines
NASH
Oncology
Opioid
Partnerships
Patient Centricity
Patient Stories
Pediatrics
Pfizer Culture
Pneumoccocal Disease
Pneumococcal Disease
Pneumonia
Precision Medicine
Prostate Cancer
Psoriasis
Pulmonary Hypertension
Rare Diseases
Research
Respiratory Syncytial Virus
Responsibility
Rheumatoid Arthritis
Sickle Cell Disease
Skin Conditions
Technology
Transthyretin Amyloidosis (ATTR)
Ulcerative Colitis
Vaccines
Vitiligo
Wellness
Women's Health
mRNA
migraine
December 2020
12.15.2020
Perspectives
Albert Bourla
Covid-19
COVID-19 Vaccine Efforts
Diseases & Conditions
Vaccines
• • •
Distributing Our COVID-19 Vaccine to the World
October 2020
10.15.2020
Perspectives
Albert Bourla
Covid-19
Diseases & Conditions
Vaccines
• • •
An Open Letter from Pfizer Chairman and CEO Albert Bourla
Page
1
Page
2
Current page
3
Cookies Preference
